[1] EHRLICH P.Contributions to the theory and practice of histological staining (Inaugural dissertation,University of Leipzig,1878) In:Collected Papers of Paul Ehrlich,vol.1.F.Himmelweit (ed.)[C].London:Pergamon Press,pp,1956:65-98.
[2] YONG L C.The mast cell origin,morphology,distribution and function[J].Exp Toxicol Phatol,1997,49(6):409-424.
[3] KIRSHENBAUM A S,KESSLER S W,GOFF J P,et al.Demonstration of the origen of human mast cells from CD34+bone marrow progenitor cells[J].J Immunol,1991,146(5):1410-1415.
[4] METCALFE D D,BARAM D, MEKORI Y A.Mast cells[J].Physiol Rev,1997,77(4):1033-1079.
[5] SIRAGANIAN R.Mast cell signal transduction from the high-affinity IgE receptor[J].Curr Opin Immunol,2003,15(6):639-646.
[6] KITAMURA Y,ITO A.Mast cell-committed progenitors[J].Proc Natl Acad Sci USA,2005,102(32):11129-11130.
[7] GRIMBALDESTON M A,METZ M,YU M,et al.Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses[J].Curr Opin Immunol,2006,18(6):751-760.
[8] ABRAHAM S N,MALAVIJA R.Mast cells in infection and immunity[J].Infec Immun,1997,65(9):3501-3508.
[9] VRANIAN G Jr,CONRAD D H,RUDDY S.Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells[J].J Immunol,1981,126(6):2302-2306.
[10] MALAVIYA R,IKEDA T,ROSS E,et al.Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha[J].Nature,1996,381(6577):77-80.
[11] WILHELM M,SILVER R,SILVERMAN A J.Central nervous system neurons acquire mast cell products via transgranulation[J].Eur J Neurosci,2005,22(9):2238-2248.
[12] HILL P B,Martin R J.A review of mast cell biology[J].Vet Derm,1998,9(3):145-166.
[13] CHRISTY A L,BROWN M A.The multitasking mast cell:positive and negative roles in the progression of autoimmunity[J].J Immunol,2007,179(5):2673-2679.
[14] ORR E L.Presence and distribution of nervous systemassociated mast cells that may modulate experimental autoimmune encephalomyelitis[J].Ann N Y Acad Sci,1988,540:723-726.
[15] IBRAHIM M Z,REDER A T,LAWAND R,et al.The mast cells of the multiple sclerosis brain[J].J Neuroimmunol,1996,70(2):131-138.
[16] DINES K C,POWELL H C.Mast cell interactions with the nervous system:relationship to mechanisms of disease[J].J Neuropathol Exp Neurol,1997,56(6):627-640.
[17] STEINMAN L.Multiple sclerosis:a two-stage disease[J].Nat Immunol,2001,2(9):762-764.
[18] BROWN M A,TANZOLA M B,ROBBIE-RYAN M.Mechanisms underlying mast cell influence on EAE disease course[J].Mol Immunol,2002,38(16-18):1373-1378.
[19] NIGROVIC P A,LEE D M.Synovial mast cells:role in acute and chronic arthritis[J].Immunol Rev,2007,217:19-37.
[20] BRENNER T,SOFFER D,SHALIT M,et al.Mast cells in experimental allergic encephalomyelitis:characterization,distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides[J].J Neurol Sci,1994,122(2):210-213.
[21] ROZNIECKI J J,HAUSER S L,STEIN M,et al.Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients[J].Ann Neurol,1995,37(1):63-66.
[22] SEELDRAYERS P,YASUA D,WEINER H,et al.Treatment of experimental allergic neuritis with nedocromil sodium[J].J Neuroimmunol,1989,25(2-3):221-226.
[23] MATSUMOTO I,STAUB A,BENOIST C,et al.Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme[J].Science,1999,286(5445):1732-1735.
[24] HUEBER A J,ASQUITH D L,MILLER A M,et al.Mast cells express IL-17A in rheumatoid arthritis synovium[J].J Immunol,2010,184(7):3336-3340.
[25] LEE D M,FRIEND D S,GURISH M F,et al.Mast cells:a cellular link between autoantibodies and inflammatory arthritis[J].Science,2002,297(5587):1689-1692.
[26] GEOFFREY R,JIA S,KWITEK A E,et al.Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat[J].J Immunol,2006,177(10):7275-7286.
[27] YAMAMOTO T,KATAYAMA I,NISHIOKA K.Mast cell numbers in multiple dermatofibromas[J].Dermatology,1995,190(1):9-13.
[28] WINTROUB B U,MIHM M C,GOETZL E J,et al.Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid[J].N Engl J Med,1978,298(8):417-421.
[29] SAINI S S,PATERNITI M,VASAGAR K,et al.Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization:Relationship to expression of Syk and SHIP-2[J].Clin Immunol,2009,132(3):342-348.
[30] ISHII T,FUJITA T,MATSUSHITA T,et al.Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction[J].Am J Pathol,2009,174(6):2225-2233.
[31] RIBATTI D,ENNAS M G,VACCA A,et al.Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma[J].Eur J Clin Invest,2003,33(5):420-425.
[32] GLIMELIUS I,EDSTRÖM A,FISCHER M,et al.Angiogenesis and mast cells in Hodgkin lymphoma[J].Leukemia,2005,19(12):2360-2362.
[33] STROUCH M J,CHEON E C,SALABAT M R,et al.Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression[J].Clin Cancer Res,2010,16(8):2257-2265.
[34] NONOMURA N,TAKAYAMA H,NISHIMURA K,et al.Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer[J].Br J Cancer,2007,97(7):952-956.
[35] ELPEK G O,GELEN T,AKSOY N H,et al.The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus[J].J Clin Pathol,2001,54(12):940-944.
[36] MOLICA S,VITELLI G,LEVATO D,et al.Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia[J].Eur J Haematol,2003,70(6):373-378.
[37] MOLICA S,VACCA A,CRIVELLATO E,et al.Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia[J].Eur J Haematol,2003,71(2):137-139.
[38] MAURER M,THEOHARIDES T,GRANSTEIN R D,et al.What is the physiological function of mast cells?[J].Exp Dermatol,2003,12(6):886-910.
[39] GALLI S J,TSAI M,WERSHIL B K,et al.Regulation of mouse and human mast cell development,survival and function by stem cell factor,the ligand for the c-kit receptor[J].Int Arch Allergy Immunol,1995,107(1-3):51-53.
[40] HUANG B,LEI Z,ZHANG G,et al.SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment[J].Blood,2008,112(4):1269-1279.
[41] TÓTH-JAKATICS R,JIMI S,TAKEBAYASHI S,et al.Cutaneous malignant melanoma:correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor[J].Hum Pathol,2000,31(8):955-960.
[42] NORRBY K,JAKOBSSON A,SÖRBO J.Mast-cell secretion and angiogenesis,a quantitative study in rats and mice[J].Virchows Arch B Cell Pathol Incl Pathol,1989,57(4):251-256.
[43] SCHWARTZ L B.Tryptase:a mast cell serine protease[J].Methods Enzymol,1994,244:88-100.
[44] BLAIR R J,MENG H,MARCHESE M J,et al.Human mast cells stimulate vascular tube formation.Tryptase is a novel,potent angiogenic factor[J].J Clin Invest,1997,99(11):2691-2700.
[45] RVGER B,DUNBAR P R,HASAN Q,et al.Human mast cells produce type VIII collagen in vivo[J].Int J Exp Pathol,1994,75(4):397-404.
[46] DYDUCH G,KACZMARCZYK K,OKOÑK K.Mast cells and cancer:enemies or allies?[J].Pol J Pathol,2012,63(1):1-7.
[47] 王喜旺,李立峰.脑转移瘤发生发展机制研究进展[J].现代肿瘤医学,2012,20(3):645-647.
[48] OLDFORD S A,HAIDL I D,HOWATT M A,et al.A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth[J].J Immunol,2010,185(11):7067-7076.
[49] MALTBY S,KHAZAIE K,McNAGNY K M.Mast cells in tumor growth:angiogenesis,tissue remodelling and immune-modulation[J].Biochim Biophys Acta,2009,1796(1):19-26.
[50] FLEISCHMANN A,SCHLOMM T,KÖLLERMANN J,et al.Immunological microenvironment in prostate cancer:high mast cell densities are associated with favorable tumor characteristics and good prognosis[J].Prostate,2009,69(9):976-981.
[51] JOHANSSON A,RUDOLFSSON S,HAMMARSTEN P,et al.Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy[J].Am J Pathol,2010,177(2):1031-1041.
[52] MAURO L V,BELLIDO M,MORANDI A,et al.Association between mast cells of different phenotypes and angiogenesis in colorectal cancer[J].Mol Med Report,2008,1(6):895-902.
[53] YOSHII M,JIKUHARA A,MORI S,et al.Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin-and MAP kinase-dependent manners[J].J Pharmacol Sci,2005,98(4):450-458.
[54] CARLINI M J,DALURZO M C L,LASTIRI J M,et al.Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance[J].Hum Pathol,2010,41(5):697-705.
[55] 杨晓琳.乳腺癌患者术前与术后性功能的比较[J].现代医学,2015,43(4):493-495.
[56] HIROMATSU Y,TODA S.Mast cells and angiogenesis[J].Microsc Res Tech,2003,60(1):64-69.
[57] DABIRI S,HUNTSMAN D,MAKRETSOV N,et al.The presence of stromal of mast cells identifies a subset of invasive breast cancers with a favourable prognosis[J].Mol Pathol,2004,17(6):690-695.
[58] BOWERS H M Jr,MAHAPATRO R C,KENNEDY J W.Numbers of mast cells in the axillary lymph nodes of breast cancer patients[J].Cancer,1979,43(2):568-573.
[59] AALTOMAA S,LIPPONEN P,PAPINAHO S,et al.Mast cells in breast cancer[J].Anticancer Res,1993,13(3):785-788.
[60] HARTVEIT F,THORESEN S,TANGEN M,et al.Mast cell changes and tumour dissemination in human breast carcinoma[J].Invasion Metastasis,1984,4(3):146-155.
[61] FISHER E R,SASS R,WATKINS G,et al.Tissue mast cells in breast cancer[J].Breast Cancer Res Treat,1985,5(3):285-291.
[62] TAN W J,THIKE A A,TAN S Y,et al.CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival[J].Mod Pathol,2015,28(3):352-358.
[63] ASHISH R,DMITRY T,MAGGIE C,et al.Stromal mast cells in invasive breast cancer are a marker of favourable prognosis:a study of 4,444 cases[J].Breast Cancer Res Treat,2008,107(2):249-257.
[64] 张友元,熊密,魏爱君,等.乳腺癌MVD、MCD检测及其意义[J].实用肿瘤杂志,2002,17(4):252-253.
[65] 龙峰,王晨红,翁彬,等.乳腺癌组织中肥大细胞和肿瘤相关巨噬细胞计数及其临床病理意义[J].医学临床研究,2004,21(8):855-857.
[66] 李淮岗,贺明盟,铁宝娴,等.间质反应在乳腺良恶性病变中的意义[J].中国基层医药,2001,8(5):437.
[67] KASHIWASE Y,MORIOKA J,INAMURA H,et al.Quantitative analysis of mast cells in benign and malignant breast lesions.Immunohistochemical study on formalin-fixed,paraffin-embedded tissues[J].Int Arch Allergy Immunol,2004,134(3):199-205.
[68] ROVERE F D,GRANATA A,FAMILIARI D,et al.Mast cells in invasive ductal breast cancer:different behavior in high and minimum hormone-receptive cancers[J].Anticancer Res,2007,27(4B):2465-2472.
[69] 赵峰.乳腺良恶性病变肥大细胞反应的研究[J].实用药物与临床,2007,10(6):342-344.
[70] 黎晴,杨梅,曹桂明.肥大细胞与乳腺浸润性导管癌淋巴结转移及淋巴管生成的关系探讨[J].海南医学,2012,23(9):7-9.
[71] NAIK R,BALIGA P,BANSAL R,et al.Distribution of mast cells in the axillary lymph nodes of breast cancer patients[J].J Indian Med Assoc,1997,95(12):606-607.
[72] UESHIMA C,KATAOKA T R,HIRATA M,et al.The killer cell Ig-like receptor 2DL4 expression in human mast cells and its potential role in breast cancer invasion[J].Cancer Immunol Res,2015,3(8):871-880.
[73] 顾漪萍,向萌,陆超,等.肥大细胞类胰蛋白酶促进人乳腺癌细胞系MDA-MB-435的跨膜侵袭[J].复旦学报:医学版,2008,35(3):407-410.
[74] XIANG M,GU Y P,ZHAO F D,et al.Mast cell tryptase promotes breast cancer migration and invasion[J].Oncology Reports,2010,23(3):615-619.
[75] 宁艳霞,周仲文,许祖德,等.类胰蛋白酶在乳腺癌组织中的表达及意义[J].复旦学报:医学版,2004,31(5):540-541.
[76] MARECH L,AMMENDOLA M,SACCO R,et al.Serum tryptase,mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients:possible translational significance[J].BMC Cancer,2014,14:534.
[77] MANGIA A,MALFETTONE A,ROSSI R,et al.Tissue remodelling in breast cancer:human mast cell tryptase as an initiator of myofibroblast differentiation[J].Histopathology,2011,58(7):1096-1106.
[78] KANKKUNEN J P,HARVIMA I T,NAUKKARINEN A.Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions[J].Int J Cancer,1997,72(3):385-388.
[79] ROVERE F D,GRANATA A,MONACO M,et al.Phagocytosis of cancer cells by mast cells in breast cancer[J].Anticancer Res,2009,29(8):3157-3162. |
